Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Abata Therapeutics
245 First Street
Cambridge, MA 02142
Phone: 617-585-2000
https://abatatx.com/

Abata's autologous Treg cell therapies are engineered to express T cell receptors (TCRs) that recognize antigens present in tissue where an autoimmune response has been triggered. This enables Abata's Tregs to target the site of disease for a robust effect without imposing systemic immune suppression.

Key Contact
Name
Samantha Singer
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
06/23/21 $95,000,000 Series A ElevateBio
Invus
JDRF T1D Fund
Samsara BioCapital
Third Rock Ventures
undisclosed